(ORIC) Oric Pharmaceuticals - Performance 3.3% in 12m
ORIC performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-49.22%
#68 in Peer-Group
Rel. Strength
44.77%
#4233 in Stock-Universe
Total Return 12m
3.26%
#57 in Peer-Group
Total Return 5y
-54.32%
#66 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 12.54 USD |
| 52 Week Low | 4.26 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 85.51 |
| Buy/Sell Signal +-5 | 0.06 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ORIC (3.3%) vs XBI (-12.9%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-0.31% | 59.8% | 74.7% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
4.3% | -9.7% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.02% | -7.68% | 38% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.08% | 26.2% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.29% | -9.49% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.7% | 37.9% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.29% | 46.5% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
0.46% | 28.5% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ORIC vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ORIC
| Total Return (including Dividends) | ORIC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 15.26% | 4.10% | 4.77% |
| 3 Months | 117.22% | 13.70% | 16.02% |
| 12 Months | 3.26% | -12.86% | 12.44% |
| 5 Years | -54.32% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | ORIC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 86.9% | 52.1% | 90.3% |
| 3 Months | 92.3% | 79.4% | 97.5% |
| 12 Months | -44.3% | -87.4% | 46.4% |
| 5 Years | -45.5% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th77.50 | 10.73% | 10.02% |
| 3 Month | %th95.00 | 91.04% | 87.23% |
| 12 Month | %th72.00 | 18.50% | -8.17% |
| 5 Years | %th67.00 | -41.47% | -78.53% |
FAQs
Does Oric Pharmaceuticals (ORIC) outperform the market?
Yes,
over the last 12 months ORIC made 3.26%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.86%.
Over the last 3 months ORIC made 117.22%, while XBI made 13.70%.
Performance Comparison ORIC vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ORIC vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.8% | 10.5% | 21.2% | -9% |
| US NASDAQ 100 | QQQ | 3.8% | 10% | 19.2% | -9% |
| German DAX 40 | DAX | 3.4% | 12.2% | 9.1% | -27% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.6% | 10.1% | 16.7% | -16% |
| Hongkong Hang Seng | HSI | 2.9% | 11.3% | -0.8% | -31% |
| India NIFTY 50 | INDA | 5.1% | 13.7% | 20.7% | 7% |
| Brasil Bovespa | EWZ | 8% | 15.6% | 6.1% | 3% |
ORIC vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5.2% | 11.7% | 17.9% | -20% |
| Consumer Discretionary | XLY | 2.8% | 10.5% | 28.9% | -14% |
| Consumer Staples | XLP | 5.8% | 14.8% | 22.1% | -4% |
| Energy | XLE | 0.8% | 13.3% | 28.7% | 3% |
| Financial | XLF | 5.2% | 10.5% | 18.9% | -20% |
| Health Care | XLV | 3.6% | 15.5% | 32.7% | 10% |
| Industrial | XLI | 3.4% | 9.7% | 15.3% | -19% |
| Materials | XLB | 3.1% | 10% | 20.5% | -0% |
| Real Estate | XLRE | 4% | 15.1% | 22.7% | -4% |
| Technology | XLK | 3.9% | 8.1% | 16.1% | -7% |
| Utilities | XLU | 3.7% | 13.3% | 17.1% | -19% |
| Aerospace & Defense | XAR | 3.1% | 8% | 1.2% | -44% |
| Biotech | XBI | 0.1% | 11.2% | 31.4% | 16% |
| Homebuilder | XHB | 0.7% | 3.9% | 27.8% | 6% |
| Retail | XRT | 3.8% | 8.5% | 26% | -3% |
ORIC vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 3.2% | 18.9% | 35.1% | 7% |
| Natural Gas | UNG | 5.5% | 24.1% | 47.2% | 0% |
| Gold | GLD | 3.7% | 17.5% | 3.3% | -35% |
| Silver | SLV | -0.6% | 9% | -0.9% | -22% |
| Copper | CPER | -6.6% | -0.7% | 1.6% | -20% |
ORIC vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 4.6% | 15.5% | 26.5% | 7% |
| iShares High Yield Corp. Bond | HYG | 4.3% | 13.9% | 24.2% | -6% |